Cell cycle regulators in testicular cancer: Loss of p18(INK4C) marks progression from carcinoma in situ to invasive germ cell tumours

International Journal of Cancer

Volumn 85, Issue 3, 2000, Pages 370-375

  Bartkova, Jirina ^a   Thullberg, Minna ^a   Rajpert De Meyts, Ewa ^b   Skakkebæk, Niels E ^b   Bartek, Jiri ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; PROTEIN P21; PROTEIN P27;

ARTICLE; CANCER GROWTH; CARCINOMA IN SITU; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GERM CELL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TERATOMA; TESTIS CANCER; TISSUE DISTRIBUTION; TUMOR DIFFERENTIATION;

ADULT; CARCINOMA IN SITU; CARRIER PROTEINS; CELL CYCLE PROTEINS; CHEMILUMINESCENT MEASUREMENTS; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DISEASE PROGRESSION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; GERMINOMA; HUMANS; IMMUNOBLOTTING; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM INVASIVENESS; TERATOCARCINOMA; TESTICULAR NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033989105     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000201)85:3<370::AID-IJC13>3.0.CO;2-A     Document Type: Article

References (27)

1. ANDREWS, P.W., Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Develop. Biol., 103, 285-293 (1984).
2. BARTEK, J., BARTKOVA, J. and LUKAS, J., The retinoblastoma protein pathway in cell cycle control and cancer. Exp. Cell Res., 237, 1-6 (1997).
3. BARTKOVA, J., BARTER, J., LUKAS, J., VOJTESEK, B., STASKOVA, Z., REJTHAR, A., KOVARIK, J., MIDGLEY, C.A. and LANE, D.P., p53 protein alterations in human testicular cancer incuding pre-invasive intratubular germ-cell neoplasia. Int. J. Cancer, 49, 196-202 (1991).
4. BARTKOVA, J., LUKAS, J., STRAUSS, M. and BARTEK, J., Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein. J. Pathol., 172, 237-245 (1994).
5. BARTKOVA, J., RAJPERT-DE MEYTS, E., SKAKKEBÆK, N.E. and BARTEK, J., D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy. J. Pathol., 187, 573-581 (1999).
6. INK4 (MTS1) gene inactivation in testicular germ cell tumors. Amer. J. Pathol., 151, 859-865 (1997).
7. Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J., 18, 1571-1583 (1999).
8. CHRESTA, C.M., MASTERS, J.R.W. and HICKMAN, J.A., Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high bax:bcl-2 ratio. Cancer Res., 56, 1834-1841 (1996).
9. DREXLER, H., Review of alterations of the cdk inhibitor INK4 family genes p15, p16, p18, and p19 in human leukemia-lymphoma cells. Leukemia, 12, 845-859 (1998).
10. Kip1 mediate two separate pathways to collaborativelly suppress pituitary tumorigenesis. Genes Develop., 12, 2899-2911 (1998).
11. GUILLOU, L., ESTREICHER, A., CHAUBERT, P., HURLIMANN, J., KURT, A.-M., METTHEZ, G., IGGO, R., GRAY, A.C., JICHLINSKI, P., LEISINGER, H.-J. and BENHATTAR, J., Germ cell tumours of the testis overexpress wild-type p53. Amer. J. Pathol., 149, 1221-1228 (1996).
12. HALL, M. and PETERS, G., Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res., 68, 67-108 (1996).
13. HARPER, J.W. and ELLEDGE, S.J., CDK inhibitors in development and cancer, Curr. Opin. Genet. Develop., 6, 56-64 (1996).
14. HOULDSWORTH, J., REUTER, V., BOSL, G.J. and CHAGANTI, R.S.K., Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Cell Growth Differentiation, 8, 293-299 (1997).
15. KEYOMARSI, K. and HERLICZEK, T.W., The role of cyclin E in cell proliferation, development, and cancer. Progr. Cell Cycle Res., 3, 171-191 (1997).
16. KRANENBURG, O., VAN DER EB, A.J. and ZANTEMA, A., Cyclin-dependent kinases and pRb: regulators of the proliferation-differentiation switch. FEBS Lett., 367, 103-106 (1995).
17. LABAER, J., GARRETT, M.D., STEVENSON, L.F., SLINGERLAND, J.M., SANDHU, C., CHOU, H.S., FATTAEY, A. and HARLOW, E., New functional activities for the p21 family of CDK inhibitors. Genes Develop., 11, 847-862 (1997).
18. LAPOINTE, J., LACHANCE, Y., LABRIE, Y. and LABRIE, C, A p18 mutant defective in CDK6 binding in human breast cancer cells. Cancer Res., 56, 4586-4589 (1996).
19. MOSTOFI, F.K., SESTERHENN, I.A. and DAVIS, C.J., World Health Organisation international histological classification of germ cell tumours of the testes. In: W.G. Jones, A. Milford Ward and C.K. Anderson (eds.), Germ-cell tumours, II, pp. 1-23, Pergamon, Oxford, UK (1986).
20. OOSTERHUIS, J.W. and LOOIJENGA, L.H.J., The biology of human germ cell tumours: retrospective speculations and new prospectives. Europ. Urol., 23, 245-250 (1993).
21. PINES, J., Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J., 308, 697-711 (1995).
22. PLEASURE, S.J. and LEE, V.M.-Y., NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neurosci. Res., 35, 585-602 (1993).
23. RAJPERT-DE MEYTS, E., JØRGENSEN, N., BRØNDUM-NIELSEN, K., MULLER, J. and SKAKKEBÆK, N.B., Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. Acta pathol. Microbiol. Immunol. Scand., 106, 198-206 (1998).
24. SICINSKI, P. and 13 OTHERS, Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature (Lond.), 384, 470-474 (1996).
25. SKAKKEBÆK, N.E., Possible carcinoma-in-situ of the testis. Lancet, ii, 516-517 (1972).
26. SKAKKEBÆK, N.E., BERTHELSEN, J.G., GIWERCMAN, A. and MULLER, J., Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int. J. Androl., 10, 19-28 (1987).
27. WELCKER, M., LUKAS, J., STRAUSS, M. and BARTEK, J., p21 Mutants deficient in inhibiting cyclin-dependent kinases can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cells. Cancer Res., 58, 5053-5056 (1998).